Iraq

Reimbursed Care Access

Iraq maintains strict national controls on narcotic and psychotropic substances under its Narcotic Drugs and Psychotropic Substances Law No. 50 (2017) and active anti‑narcotics enforcement; most classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are criminalized with no authorized medical/reimbursement pathways outside approved research. Ketamine is widely used and available within clinical practice in Iraq as an anesthetic/analgesic in public and private hospitals, but specialized psychedelic medicines (esketamine, regulated psilocybin/MDMA treatments) do not have an established reimbursed regulatory framework. National authorities (Ministry of Health, Interior Ministry anti‑narcotics directorates) emphasize interdiction and control while also operating routine medical supply/registration systems for approved medicines. [https://ojs.uomosul.edu.iq/index.php/alaw/article/view/49027|Iraqi Law No.50 analysis] [https://treaties.un.org/Pages/showActionDetails.aspx?clang=_en&objid=080000028000828f|UN Treaty accession record].